Painchek (ASX:PCK) Accounts Payable: A$1.61 Mil (As of Dec. 2025)


ASX:PCK Painchek Ltd ASX:PCK
52 GF Score
Price A$0.11
GF Value A$0.40
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Painchek Accounts Payable?

Painchek ASX:PCK 52 Accounts Payable is A$1.61 Mil as of Dec. 2025. GuruFocus rates ASX:PCK with a GF Score™ of 52/100 and a GF Value™ of A$0.40 (Possible Value Trap). The stock has 3 warning signs investors should review.

Painchek's Accounts Payable for the quarter that ended in Dec. 2025 was A$1.61 Mil.

Painchek's quarterly Accounts Payable declined from Dec. 2024 (A$2.61 Mil) to Jun. 2025 (A$0.80 Mil) but then increased from Jun. 2025 (A$0.80 Mil) to Dec. 2025 (A$1.61 Mil).

Painchek's annual Accounts Payable increased from Jun. 2023 (A$0.50 Mil) to Jun. 2024 (A$0.84 Mil) but then declined from Jun. 2024 (A$0.84 Mil) to Jun. 2025 (A$0.80 Mil).

Painchek Accounts Payable Historical Data

* Premium members only.

The historical data trend for Painchek's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Painchek Accounts Payable Chart

Painchek Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.28 0.50 0.84 0.80

Painchek Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.19 0.84 2.61 0.80 1.61
ASX:PCK
52GF Score
Painchek Ltd ASX:PCK
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Painchek Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$1.61 Mil mean?
Painchek (ASX:PCK) has a Accounts Payable of A$1.61 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Painchek and its competitors.
Is Painchek's Accounts Payable too high?
Painchek's current Accounts Payable is A$1.61 Mil. Overall, Painchek has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Painchek's Accounts Payable compare to VEEV and BTSG?
Painchek's Accounts Payable of A$1.61 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Painchek and its competitors. Painchek's current Accounts Payable is A$1.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Painchek stock overvalued right now?
Based on GuruFocus' analysis, Painchek (ASX:PCK) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.11 — trading 73.8% below its estimated fair value. The current Accounts Payable is A$1.61 Mil. Painchek's overall GF Score™ is 52/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Painchek (ASX:PCK), the current Accounts Payable is A$1.61 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Painchek (ASX:PCK) Overvalued in 2026?

Based on GuruFocus' analysis, Painchek stock appears to be undervalued. The current stock price of A$0.11 is trading 73.8% below its estimated GF Value™ of A$0.40. GuruFocus considers Painchek to be Possible Value Trap.

Key valuation signals for ASX:PCK:

  • Accounts Payable: A$1.61 Mil
  • GF Value™: A$0.40 vs. price of A$0.11 (73.8% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ASX:PCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Painchek Business Description

Address 35 Lime Street, Suite 401, Sydney, NSW, AUS, 2000
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.
52GF Score

Get the complete analysis for ASX:PCK

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.11
Price
A$0.40
GF Value